Here are five takeaways:
1. By 2022, the market is expected to hit $1.63 billion.
2. The market was valued at $523 million last year.
3. In 2015, the hospital-acquired pneumonia and urinary tract infection segment collaboratively had a 50 percent market share.
4. North America has the largest regional presence in the market due to a high number of hospital stays and prevalence of healthcare-acquired infections.
5. Diatherix, Roche, Cantel Medical, Qiagen, Cephid and bioMeriux are key market vendors.
More articles on quality & infection control:
10% boost in hand hygiene compliance reduced HAIs by 6%: 4 takeaways
3 tips when disclosing medical errors
Valeritas names Erick Lucera new CFO — 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
